Expansion of ST2-expressing macrophages in a patient with bronchiolitis obliterans syndrome

Authors:

Abstract
Bronchiolitis obliterans syndrome (BOS) is a major complication of haematopoietic stem cell transplantation (HSCT), which affects the lungs and has limited treatment options [1]. BOS after HSCT is considered a manifestation of chronic graft-versus-host disease (GVHD). T-cells play a crucial role in its onset [2], while the contribution of myeloid cells has been largely unknown.
Funding Information
  • Japan Agency for Medical Research and Development
  • Boehringer Ingelheim
  • the Kakihara Foundation